August 21, 2007 - Omicia Inc., a privately held company specializing in personalized genetic signatures for early detection of disease risk, has been awarded its fourth NIH grant, a $182,732 Small Business Technology Transfer (STTR) Phase I grant from the National Heart, Lung, and Blood Institute of the National Institutes of Health, aiming to identify genes whose variants increase the risk of developing cardiovascular disease.

This industry/academia collaboration is between Omicia and Johns Hopkins University (JHU).

August 21, 2007 - Researchers at Rensselaer Polytechnic Institute have developed a new energy storage device that could reportedly be mistaken for a simple sheet of black paper, geared toward meeting the trickiest design and energy requirements of tomorrow's implantable medical equipment.

August 21, 2007 - Defibtech LLC, a designer and manufacturer of automated external defibrillators (AEDs), announced today that the company has shipped more than 50,000 of its DDU-100 Series AEDs marketed under the brand names of Lifeline and ReviveR.

Defibtech AEDs were reportedly selected by the 2006 Winter Olympic Games in Torino, Italy and have been the AEDs of choice for statewide deployment programs in Arkansas, Florida, Idaho, Louisiana, Maine, New Hampshire, New Jersey, New Mexico, Utah and elsewhere.


Ice packs and cold compresses have been used for centuries to reduce swelling and fevers. But it’s only been within the last five years that clinicians have witnessed the dramatic results — especially in patients who have suffered a cardiac arrest — that can be achieved through induced hypothermia.



Controlling normothermia in perioperative patients can be almost as important to their health as the surgical procedure itself. Research is revealing more and more the negative implications of even small dips in patient temperature.



Induced hypothermia has traditionally been used perioperatively as a strategy for neurological protection during major vascular surgery or for situations where neurological injury is present or imminent. However, patients cannot deviate off of the normal core body temperature of around 37°C for long without risk of deleterious effects.



In the years since 9/11, disaster medicine has come into its own. Now a recognized specialty, the practice of disaster preparedness, disaster planning, disaster response and disaster recovery as it relates to the practice of medicine and the function of healthcare and healthcare institutions has moved from the realm of the emergency manager and hospital safety officer into the realm of the healthcare professional.


August 20, 2007 - Cardiatis, SA announced that it has completed recruitment of patients into its first European clinical trial of its 3D Multilayer Braided Stent for repairing aneurysms.

August 15, 2007 - Performing cardiac CTA after coronary artery bypass surgery (CABG) can reveal unsuspected and potentially significant findings beyond the heart, according to a recent study conducted by researchers at the University of Maryland School of Medicine, located in Baltimore, MD.

August 15, 2007 - Thoratec Corp., a world leader in products to treat cardiovascular disease, said today that its PMA (PreMarket Application) seeking approval of its HeartMate II for bridge-to-transplantation will undergo review by an FDA advisory panel later this year.

Subscribe Now